Is there a high-risk subgroup of stage I epithelial ovarian cancer that is most likely to benefit from 6 versus 3 cycles of adjuvant chemotherapy?

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples